Excellence Health and GEEN Bio Sign MOU for Potential Strategic Partnership

Excellence Health and GEEN Bio Sign MOU for Potential Strategic Partnership

Press Release (ePRNews.com) - LAS VEGAS - Mar 02, 2018 - Excellence Health Inc., an international pharmaceutical company and GEEN Biotechnology, Inc., a synthetic virology startup today announced the signing of a memorandum of understanding (MOU) for the companies to establish a Research Alliance for Oncolytic Viruses.

The companies are currently exploring a potential cooperation for the joint research & development as well as commercialization of a candidate from GEEN
Bio’s Intellivir platform and other current research projects within the field of oncolytic viruses.

Should both companies decide to enter an agreement, Excellence Health will co-develop GEEN Bio’s viruses, fund the R&D and conduct the clinical trials. GEEN Bio will allow Excellence Health to commercialize the co-developed therapies in return for a fixed percentage of the marketed product’s revenue.

This partnership is going to be the official beginning of a historical change in the fields of both synthetic virology and cancer immunotherapy. We are exploring an intersecting field between advanced genetic engineering, viruses, cancer, and evolution. Such alliances have pioneering roles in the inevitable emergence of synthetic viruses as the most powerful and versatile tools of modern medicine.

Arda D. Dokuzoglu

CEO & CTO

“Our intent to explore a range of business opportunities with GEEN Bio is an example of our commitment to expand our Oncology portfolio and to support innovative startup companies,” said Luca L. J. de la Torre, Director, Business Development of Excellence Health Inc. “GEEN Biotechnology has been on our radar for about a year now and we look
forward to establishing the research alliance.”

Arda D. Dokuzoglu, CEO, and CTO of GEEN Biotechnology, Inc. stated, “This partnership is going to be the official beginning of a historical change in the fields of both synthetic virology and cancer immunotherapy. We are exploring an intersecting field between advanced genetic engineering, viruses, cancer, and evolution. Such alliances have pioneering roles in the inevitable emergence of synthetic viruses as the most powerful and versatile tools of modern medicine.”

About Excellence Health Inc.:

Excellence Health is a family-owned pharmaceutical company headquartered in Las Vegas, Nevada with 17 offices in the U.S. and 29 offices in other countries. Excellence Health is present on every continent.

We acquire the rights for to-be commercialized drugs and then out-license the rights to other pharmaceutical companies for manufacturing and marketing. Our company conducts research through our subsidiaries and actively invests in R&D projects globally. Our partners are independent R&D companies but also leading universities worldwide. We assist our partners in collaboration projects through the financing of the research, expert advice from renowned scientists, world-class lab space and the commercialization of the developed drug. Excellence Health currently operates more than 38 surgery centers and hospitals in the US and Dubai, UAE and are able to conduct in-house clinical trials.

About GEEN Biotechnology, Inc.:

GEEN Biotechnology, Inc. is a multinational synthetic virology start-up with business operations in the U.S. and has its research center in Istanbul, Turkey.
GEEN is developing a platform for next-gen oncolytic viruses called Intellivir. These intelligent viruses differentiate from competitors by their ability to rapidly learn and adapt guided by their synthetically reassigned evolutionary objectives. GEEN uses this technology to improve the potency of current oncolytic viruses. We are blending cutting-edge developments in the field of synthetic biology with
our specific know-how of engineering complex organisms and viruses to translate these concepts directly into cancer therapy strategies. We are dedicated to bringing synthetic viruses into practical human life as the ultimate agents of biological
protection, therapy, and enhancement.

Media Contact

Company Name: Excellence Health Inc.
Contact Person: Kylie Santos
Email: pr@excellencehealth.org
Phone: +1 (702) 500-1225
Address: 7252 W Lake Mead Blvd
City: Las Vegas
State: NV 89128
Country: United States
Website: http://www.excellencehealth.org

Company Name: GEEN Biotechnology, Inc.
Contact Person: Arda D. Dokuzoglu
Email: add@geenbio.com
Phone TR: +90 (537) 506-2211
Phone US: +1 (650) 353-3571
Address: Istanbul Uni. Avcilar Kamp. Sankara Arastirma Merkezi
City: Avcilar
State: Istanbul 34320
Country: Turkey
Website: http://www.geenbio.com

Source : GEEN Biotechnology, Inc.
SHARE :  

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.